PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
5.24%
Revenue growth below 50% of CRK's 30.72%. Michael Burry would check for competitive disadvantage risks.
19.71%
Cost growth above 1.5x CRK's 8.59%. Michael Burry would check for structural cost disadvantages.
-7.67%
Gross profit decline while CRK shows 990.97% growth. Joel Greenblatt would examine competitive position.
-12.27%
Margin decline while CRK shows 781.61% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
-19.31%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
No Data
No Data available this quarter, please select a different quarter.
-81.82%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-4.76%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
9.87%
Total costs growth 1.1-1.25x CRK's 8.15%. Bill Ackman would demand justification.
22.50%
Interest expense growth above 1.5x CRK's 11.32%. Michael Burry would check for over-leverage.
16.08%
D&A growth above 1.5x CRK's 5.72%. Michael Burry would check for excessive investment.
4.68%
EBITDA growth below 50% of CRK's 76.27%. Michael Burry would check for structural issues.
-5.58%
EBITDA margin decline while CRK shows 20.49% growth. Joel Greenblatt would examine position.
-12.05%
Operating income decline while CRK shows 376.95% growth. Joel Greenblatt would examine position.
-16.44%
Operating margin decline while CRK shows 311.87% growth. Joel Greenblatt would examine position.
21.28%
Other expenses growth 50-75% of CRK's 32.83%. Bruce Berkowitz would examine cost efficiency.
-10.07%
Pre-tax income decline while CRK shows 130.47% growth. Joel Greenblatt would examine position.
-14.55%
Pre-tax margin decline while CRK shows 123.31% growth. Joel Greenblatt would examine position.
-112.87%
Tax expense reduction while CRK shows 124.98% growth. Joel Greenblatt would examine advantage.
20.83%
Net income growth below 50% of CRK's 132.21%. Michael Burry would check for structural issues.
14.81%
Net margin growth below 50% of CRK's 124.64%. Michael Burry would check for structural issues.
9.63%
EPS growth below 50% of CRK's 131.24%. Michael Burry would check for structural issues.
9.70%
Diluted EPS growth below 50% of CRK's 131.24%. Michael Burry would check for structural issues.
9.74%
Share count reduction below 50% of CRK's 0.12%. Michael Burry would check for concerns.
10.17%
Diluted share reduction below 50% of CRK's 0.12%. Michael Burry would check for concerns.